Breadcrumb AMCP.org Resource Center AMCP Submits Comments to CMS on Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page 1/25/19 AMCP Submits Comments to CMS on Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency Tags: Legislation & Regulation (151) Medicaid (6) Medicare (19) Medicare Part D (48) Price Transparency (22) Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page